Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report
Academic Article
Publication Date:
2021
Iris type:
1.1.2. Articolo in Rivista - Letter, Note
Keywords:
chronic lymphocytic leukemia; COVID-19; targeted agents; vaccination; Aged; COVID-19; Disease Management; Female; Humans; Italy; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Prognosis; SARS-CoV-2; Time Factors; Vaccination
List of contributors:
Cuneo, A.; Rigolin, G. M.; Coscia, M.; Quaresmini, G.; Scarfo', L.; Mauro, F. R.; Motta, M.; Quaglia, F. M.; Trentin, L.; Ferrario, A.; Laurenti, L.; Reda, G.; Ferrari, A.; Pietrasanta, D.; Sportoletti, P.; Re, F.; De Paoli, L.; Foglietta, M.; Giordano, A.; Marchetti, M.; Farina, L.; Del Poeta, G.; Varettoni, M.; Chiurazzi, F.; Marasca, R.; Malerba, L.; Ibatici, A.; Tisi, M. C.; Stefoni, V.; Leone, M.; Barate, C.; Olivieri, J.; Murru, R.; Gentile, M.; Sanna, A.; Gozzetti, A.; Gattei, V.; Gottardi, D.; Derenzini, E.; Levato, L.; Orsucci, L.; Penna, G.; Chiarenza, A.; Foa, R.
Published in: